There are currently no clear guidelines for changing brands of GLP-1 agonists
Analysts expect Lilly to generate over 21% more revenue and adjusted earnings to grow over 40% in 2026 compared to 2025 estimates, according to LSEG data
Lifestyle habits solidified for long-term success
From the GLP Collection range, handled with the same preparation steps as this one
Convenience Factors While the thought of weekly injections might seem daunting, many patients find them more convenient than daily pills with strict timing requirements
During an episode of her podcast "Dumb Blonde," Bunnie, whose real name is Alyssa DeFord, revealed that she had been taking a new drug by Lilly called retatrutide (reta), which is currently in late-stage trials and not approved by the FDA